Novo Nordisk
A page on organisations in our medical research coverage, part of our health reporting, alongside the 3 reports filed on it so far.
Novo Nordisk partners with Anthropic to accelerate drug discovery
Novo Nordisk has entered a collaboration with AI company Anthropic to speed up drug discovery and development.
Novo Nordisk ends two more phase 3 trials
Novo Nordisk has discontinued two late-stage heart failure trials for its drug ziltivekimab after a data review.
Novo Nordisk CEO Warns of Growing Competition in Obesity Drug Market
Novo Nordisk's CEO believes investors are underestimating the demand for differentiation among obesity drugs, and that new treatment options like...